NCI Data Jamboree (Project Abstract Submission): Submission #18

Submission information
Submission Number: 18
Submission ID: 186563
Submission UUID: e5da11a9-e683-4f94-9a8a-36a077ec0c99

Created: Wed, 07/15/2026 - 02:55
Completed: Wed, 07/15/2026 - 03:08
Changed: Wed, 07/15/2026 - 03:08

Remote IP address: 10.208.24.175
Submitted by: Anonymous
Language: English

Is draft: No
First Name ABDUL KAREEM
Middle Initial
Last Name SHAIK
Degree(s) PHARM.D
Position/Title/Career Status
Organization GLENFIELD MALLA REDDY BRAIN HEART HOSPITAL
Organization Address HYDERABAD
Email abdulkareemgmbhh@gmail.com
List of Additional Authors
Abstract Category Building study cohorts (e.g., with visualization capabilities)
Abstract Keywords clinical pharmacy, cohort building, stroke, pharmacovigilance, real-world evidence
Abstract Title Clinical Pharmacist Seeking Collaboration on Cohort Building and Visualization for Neuro-Cardiac Real-World Data
Abstract I am a Clinical Pharmacist at Glenfield Malla Reddy Brain Heart Hospital, Hyderabad, a tertiary neuro-cardiac referral centre with a high volume of stroke, acute coronary syndrome, and critical care admissions. My routine work involves medication reconciliation, therapeutic drug monitoring, adverse drug reaction (ADR) documentation, and antimicrobial stewardship, which regularly generates rich longitudinal patient-level data that remains under-utilised for research.
I am particularly interested in projects that build structured study cohorts from real-world hospital data and layer intuitive visualization on top, so that clinicians can explore treatment patterns, ADR signals, and outcomes interactively. I want to contribute a frontline pharmacy perspective on data quality, medication coding, and clinically meaningful variables, while learning cohort definition workflows, common data models, and dashboarding tools from the wider team.
My current skills include Excel-based data curation, structured ADR reporting, and introductory R; I am comfortable working with de-identified clinical datasets and standard drug/disease terminologies. I do not yet have a ready-to-go team and am seeking to join an existing project.
Through the 3-day jamboree, I hope to gain hands-on experience in end-to-end cohort construction and visualization, build collaborations with clinicians, data scientists, and bioinformaticians, and return equipped to lead pharmacy-driven cohort and pharmacovigilance research at my institution including a planned ADR surveillance and thrombolysis outcomes cohort at Glenfield Malla Reddy Brain Heart Hospital.